From the company's website regarding Hepatitis C in-house pipeline....
"We believe that completing this work will provide us with valuable data that supports our ddRNAi technology platform and other pipeline programs."
The only other data that they really haven't released is efficacy in the truest sense...some kind of viral load effect. Otherwise, what other data would they release that would be new?
- Forums
- ASX - By Stock
- BLT
- Panno speaks on recent changes
Panno speaks on recent changes, page-31
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online